Vanderbilt study finds new mechanism for cancer drug resistance
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer. Vanderbilt researchers have discovered a novel non-genetic cause of resistance to cetuximab. Their findings were reported in Nature Medicine. October 17, 2017